BC Cancer Foundation - Winter 2015 - (Page 10)
hundreds of new drugs have been
uncovered, which are both more
effective and have fewer side effects.
Today, experts recognize more than
60 different types of lymphoid cancers,
all of which are treatable and many
of which can be cured.
Even with positive outcomes now
seen for the majority of lymphoid cancers, experts like Dr. Randy Gascoyne,
distinguished scientist and co-director
of the CLC, are continuing to push the
research agenda forward, hoping to
achieve better results for B.C. patients.
Solving
the Mystery
of Treatment
Failure
Game-changing test developed
for lymphoid cancer
W
ith a brilliant team of
researchers, a comprehensive tumour tissue
bank and an outcomes
database, the BC Cancer Agency's
Centre for Lymphoid Cancer (CLC) has
become one of the top lymphoid cancer
research centres in the world.
10
PARTNERS IN DISCOVERY
Lymphoid cancer research is a high
priority for both the BC Cancer Agency
and BC Cancer Foundation-it remains
the fourth most common cancer type
seen in Canadians and has increased
in incidence over the last 70 years.
But as researchers' knowledge of the
biology of lymphoma has expanded,
DISCOVERING THE CAUSES
OF TREATMENT FAILURE
This year, approximately 300 British
Columbians will be diagnosed with
follicular lymphoma, a common
sub-type of non-Hodgkin lymphoma.
While many follicular lymphoma
patients can initially be treated successfully with a single therapy, patients
who present symptoms or have larger
tumour masses require a combination
of drugs. For these "high-risk" patients,
the five-year survival rate is only 50 per
cent in contrast to 90 per cent for "lowrisk" patients.
Dr. Gascoyne, together with PhD
candidate Dr. Robert Kridel and collaborators in Germany and the United
States, has spent the past two years
studying the genetic factors that
cause treatment failure in follicular
lymphoma. His goal: to stratify highand low-risk patients in order to offer
the most precise and effective therapies at the time of diagnosis, before
the disease has a chance to progress.
COLLABORATION
BENEFITING THE GLOBAL
COMMUNITY
Like so many of the most successful
cancer research initiatives, a desire
to locate the cause of treatment
Table of Contents for the Digital Edition of BC Cancer Foundation - Winter 2015
BC Cancer Foundation - Winter 2015
Opening Thoughts
Healthy Insights
Why I Give
Researcher Profile
A Monumental Leap in Cancer Treatment
Solving the Mystery of Treatment Failure
A Picture with Life- Saving Properties
Legacy Giving
BC Cancer Foundation - Winter 2015
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2018spring
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2017winter
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2017fall
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2017donorreport
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2017spring
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2016winter
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2016fall
https://www.nxtbook.com/nxtbooks/manifest/bccancer_impactreport2016
https://www.nxtbook.com/nxtbooks/manifest/bccancer_2016spring
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015winter
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015fall
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015report
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2015spring
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014winter
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014fall
https://www.nxtbook.com/nxtbooks/mcmurry/bccancer_2014report
https://www.nxtbookmedia.com